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Detection of micropollutants such as steroid hormones occurring in the aquatic environment at 
concentrations between ng/L and µg/L remains a major challenge, in particular when treatment 
efficiency is to be evaluated. Steroid hormones are typically analysed using mass-spectrometry 
methods, requiring pre-concentration and/or derivatisation procedures to achieve required detection 
limits. Free of sample preparation steps, the use of radiolabelled contaminants with liquid scintillation 
counting is limited to single-compound systems and require a separation of hormone mixtures before 
detection. In this work, a method was developed coupling ultra-high-pressure liquid chromatography 
(UHPLC) with flow scintillation analysis (FSA) for separation and detection of radiolabelled estrone, 
17ß-estradiol, testosterone and progesterone. Adjustment of the flow rate of scintillation liquid and 
UHPLC mobile phase, gradient time, column temperature, and injection volume allowed the separation 
of steroid hormones and degradation products. The limit-of-detection (LOD = 1.5–2.4 ng/L) and limit-
of-quantification (LOQ = 3.4–4.3 ng/L) for steroid hormones were comparable with the current state-of-
the-art technique (LC-MS/MS) for non-derivatised compounds. Although the method cannot be applied 
to real water samples (unless spiked with radiotracers), it serves as a useful tool for the development of 
water treatment technologies at laboratory scale as demonstrated via: i) adsorption on polymer-based 
spherical activated carbon, ii) retention in nanofiltration, iii) photodegradation using a photocatalytic 
membrane.
Water-borne trace contaminants such as pharmaceuticals, personal care products, and pesticides – collectively 
known as micropollutants – remain a serious issue due to the persistence and toxicity of such compounds1. 
The endocrine-disrupting effect of some micropollutants can cause drastic changes in the central nervous 
system as well as gender differentiation problems in wildlife and humans2,3. Steroid hormones, in particular 
naturally-occurring estrone (E1) and 17ß-estradiol (E2), exhibit the most potent endocrine-disrupting effect4. 
Other important steroid hormone intermediates are testosterone (T) and progesterone (P), whose relative est-
rogenic activity is two orders of magnitude lower than that of E25. Indeed, E2 was demonstrated to produce an 
endocrine-disrupting effect even at sub-nanogram-per-litre concentrations6.
Given the pollutant type and technology employed, the removal efficiency of conventional wastewater treat-
ment plants may vary greatly7–10. The incomplete removal of steroid compounds may result in a significant envi-
ronmental impact caused by residual concentrations and synergistic effect of complex hormone mixtures9,11. 
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Increased concentrations of steroid hormones (in particular E1 and E2) have been detected in surface waters 
(up to 137 ng/L of E2)12,13 and groundwaters (up to 147 ng/L of E2)14 as well as in the effluent of wastewater 
treatment plants (up to 143 ng/L of E1)10,15. The origins of the steroid hormones are mostly anthropogenic, with 
the most prominent example being their excretion due to hormonal therapies or the use of contraceptive pills16. 
With legislative control of micropollutants being still under development, a recent European Parliament Decision 
(EU) 2018/840 includes certain steroid hormones in the watch list of substances for close monitoring, including 
17α-ethinylestradiol, E1, and E217.
To meet stringent quality standards (maximum concentration of 0.4 ng/L for E2)18, advanced water treat-
ment technologies need to be used19,20. However, the removal of water-borne micropollutants is closely inter-
twined with the sensitivity of detection methods21. The detection and quantitation of micropollutants with 
conventional mass-spectroscopy methods involves additional sample preparation steps, such as derivatisation 
and pre-concentration, to achieve better sensitivity. Due to the non-polar nature of steroid hormones, the ion-
isation of non-derivatised, low-concentration estrogens in conventional electrospray ionisation mode is rather 
low22. A derivatisation step, in turn, transforms analytes to compounds with an additional moiety to improve 
ionisation23 and, if needed, volatility and better thermal stability24. As increasing the injected analyte mass on 
column is desired, pre-concentration (enrichment process) may be performed using extraction techniques, such 
as solid-phase extraction (SPE). These require often the large sample volumes that may not be available in lab-
oratory experiments. Further, the above procedures not only extend the analysis time and reduce the sample 
throughput25, but may also become an additional source of error due to variation of recovery26 or incomplete 
derivatisation27.
The two most powerful analytic techniques for steroid hormones are either separation-based gas chromatog-
raphy (GC) or liquid chromatography (LC), both coupled with tandem mass spectrometry (MS/MS)28,29. The 
GC-MS/MS technique exhibits excellent chromatographic resolution25 and extremely low limits-of-detection 
(LOD) of estrogens, down to 0.1 ng/L after pre-concentration and derivatisation12. Despite these advantages, the 
GC-MS/MS technique remains less attractive for water analysis, due to the requirement of off-line sample prepa-
ration procedures like pre-concentration and derivatisation.
Instead, LC-MS/MS has become the preferred analytical method for hormone compounds with a wide range 
of polarity26,30, given the short analysis time and high throughput of samples not requiring derivatisation step24,25. 
After additional pre-concentration with SPE and, if desired, derivatisation of analytes, the limit-of-quantification 
(LOQ) using LC-MS/MS may be as low as 0.17 ng/L for E222. Usually, such low reported values can be achieved 
through off-line SPE procedures and require a large sample volume (0.25–4 L) of the surface water31–33. On-line 
SPE methods developed in the last decade allow the loading of low volume samples (<1–10 mL) at LOQs as low 
as 0.5 ng/L34–36. However, the challenges and discrepancies in compound recovery and the errors introduced 
by the SPE cartridge remain37,38. Without prior extraction or derivatisation of steroid hormones, the sensitivity 
of state-of-the-art LC-MS/MS instruments is estimated to be at least 30 times higher (LOQ of 5 ng/L for E2)39. 
Nevertheless, the analysis errors at low concentrations (1–10 ng/L) achieved in case of high removal (90–99%) 
may jeopardise the quality of data for the treatment of hormone-containing waters. Thus, laboratory studies 
that involve measurement of low-volume samples (<10 mL) with residual concentrations of micropollutants 
(1–10 ng/L) remain difficult.
The method of liquid scintillation counting (LSC) has been used extensively in life sciences for the deter-
mination of isotope-labelled steroids40. The principle of LSC is based on measuring the photon emission from 
the energy transfer of radionuclide decay to a scintillation liquid41. The long-lived, low-energy β-emitting 
3H-(tritium) and 14C-(carbon-14) isotopes are the most frequently used radiolabels. Tritium-labelled compounds 
are attractive due to their highest specific activity, easier handling and simple synthesis42. Although scintillation 
methods cannot be applied to real (natural) water samples that do not contain radiotracers, these methods can 
serve as a useful analytical tool capable of detecting ng/L concentrations and requiring low sample volumes43. In 
terms of sensitivity, such a method offers one of the lowest LOD’s for micropollutants (0.1–0.9 ng/L for E1 and 
E2)44,45. Despite the high sensitivity and accuracy for low-activity samples46, the LSC method lacks the ability to 
separate mixtures of analytes or detect the degradation of a compound as the measured 3H-bearing entity.
A classical approach to solve the problem of the mixture analysis is to use HPLC separation with subsequent 
fractionation of eluate and off-line analysis of samples with LSC. Besides the fact that the manual handling of hun-
dreds of samples greatly increases the analysis time47, the lack of volume of collected fractions worsens the peak 
resolution. The aforementioned problems (long analysis time and poor resolution of the reconstructed radiochro-
matograms) can be solved, by using, for example, off-line microplate scintillation counting (MSC) coupled with 
rapid fractionation (1–2 s/well)48. The benefits of the MSC method, however, diminish as the solvent evaporation 
stage may lead to a loss of volatile components49, hence requiring the determination of recovery of radioactive 
compounds50.
Flow scintillation analysis (FSA), free of any sample preparation or manual operations, measures the radio-
active activity in-line in a flow-cell. As an in-line detector, it can be coupled with HPLC, rendering it well-suited 
for the analysis of radiolabelled compounds in mixtures or the monitoring of their degradation. FSA is one of 
the preferred techniques for metabolite and drug analysis in biological or medical sciences42,49, where a high 
throughput of relatively low-concentrated samples is required47. There are several reports of coupling FSA with 
HPLC separation. For example, HPLC connected with FSA and MS was used by Tykva et al. for the separation 
and detection of biodegradation products of juvenoid diastereoisomers (hormones)51. Under acetonitrile-water 
gradient elution, the 200 μL of degradation products were injected, monitored using the ultraviolet (UV) detector 
and quantified using an FSA-radiodetector. The LOD (defined as a signal-to-noise ratio of 3) was at a concen-
tration of 2 μg/L (equivalent to 150–200 Bq). Abdel-Khalik et al. examined the metabolites of 14C-cholesterol) 
using an HPLC-FSA technique, with the method developed using unlabelled hormones and measured by a UV 
detector52. After the external SPE step with an enrichment factor of 5, the LOD for the resulting method (0.2 mL 
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injection) was at 71.5 μg/L. Pettersson et al. used the HPLC-FSA method in order to detect the metabolites of 
5α-androstane-3α,17β-diol53. After the 50-times enrichment (from 5 to 0.1 mL), the analytes of 3α-adiol (0.1 mL, 
15.2 mg/L) were separated with a methanol/water gradient elution and analysed using an FSA-detector, although 
no LOD value was reported53.
Given the above studies using the HPLC-FSA method, the key challenge remains on how to extend the LOD 
from the μg/L range to ng/L of radiolabelled hormones. In the last two decades, the development of columns with 
small-size (less than 2 μm) particles brought an era of ultra-high performance liquid chromatography (UHPLC) 
known for high operating pressure, increased resolution and reduced runtime54. However, studies reporting the 
use of UHPLC-FSA analysis of radiolabelled hormones could have to date not been published. To explain the lack 
of research, it must be noted that low peak volumes (10–20 µL) achieved with state-of-the-art UHPLC columns 
are not well compatible with large-volume flow cells (150–1000 µL) of FSA-detectors55. Such combinations result 
in a severe peak dispersion that causes a loss of sensitivity and poor peak resolution. Yet, the method appears to 
offer potential to achieve very low detection limits, while achieving the separation of hormones in mixtures and 
the quantification of degradation products.
Thus, the outstanding research questions are as follows: (i) how can steroid hormone micropollutants at ng/L 
concentrations be detected in sample volumes of <1 mL?; (ii) how can the peaks of eluting hormones in mixtures 
be resolved using the UHPLC-FSA method?; and (iii) how can hormone mixtures and their degradation products 
be quantified?
In this work, the results of the separation of four steroid hormones (estrone, estradiol, testosterone, and pro-
gesterone) in ng/L concentrations are presented. The method development includes the variation of both liquid 
scintillation (LS) pump and UHPLC flow rates, gradient time, column temperature, the volume of injection, as 
well as the estimation of the RS values, which are the key figure-of-merit in the analytical separation process. 
The sensitivity of the method (evaluated via LOQ) was compared with those reported for LC-MS/MS analysis of 
non-radiolabelled estrogens.
To demonstrate the applicability of this method in water treatment research, we conducted three examples of 
using the UHPLC-FSA method for the quantification of steroid hormone mixtures: (i) adsorption studies with 
hormone mixtures using polymer based spherical activated carbon (PBSAC)56; (ii) membrane filtration experi-
ments using mixtures in nanofiltration57; and (iii) degradation products after photocatalysis.
Methods
Chemicals. Radiolabelled [2,4,6,7–3H(N)]-estrone (E1, 1 mCi, 3.69·1012 Bq/mmol, Batch No 2165951), 
[2,4,6,7-3H(N)]-estradiol (E2, 1 mCi, 3.48·1012 Bq/mmol, Batch No 2354825), [1,2,6,7-3H(N)]-testosterone (T, 
1 mCi, 3.53·1012 Bq/mmol, Batch No 2151380) and [1,2,6,7-3H(N)]-progesterone (P, 1 mCi, 3.57·1012 Bq/mmol, 
Batch No 2136265) were supplied in ethanol (PerkinElmer LAS GmbH, Germany). The structure of the chemicals 
and their properties are summarised in Supplementary Table S1. Diluted tritium water (HTO, volume activity of 
2.4· 1010 Bq/L) was obtained from the Institute for Technical Physics (ITEP), within KIT. UHPLC-grade methanol 
was purchased from Fischer Scientific (Germany). Ultrapure water (Milli-Q, type 1, Merck Millipore; >18.2 MΩ/
cm at 25 °C) was used in all experiments. The feed solutions of steroid hormones demonstrated in application 
examples were prepared from the different E2 batch (3.26·1012 Bq/mmol, Batch No 2526124) in a background 
solution containing 1 mM of sodium bicarbonate (99.7%, Bernd Kraft, Germany) and 10 mM of sodium chloride 
(99.9%, VWR Chemicals, Germany).
Sample preparation. A stock solution of each steroid hormone (10 µg/L) was prepared by dilution with 
ultrapure Milli-Q water of the as-supplied solution. The hormone concentration in this native solution (cnat) was 
calculated from Eq. (1)
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⋅
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where atot is the total activity in purchased solution of hormone (Bq), (1 mCi = 3.7·107 Bq), as is the specific activ-
ity of hormones in the purchased solution (Bq/mmol) (variability of activity in stock solution was not observed 
as long as the same batch of purchased solution was used), M is the molecular weight of specific hormone (g/
mol) as reported in Supplementary Table S1, and Vnat is the volume of as-purchased hormone solution (L). The 
concentration of hormone (cH) is related to the volume activity (aV) via Eq. (2):
= ⋅a a
M
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where aV is the volume activity of a sample (Bq/L) and cH is the mass concentration of hormones (g/L).
For each hormone, a series of solutions with concentrations of 1, 2, 5, 10, 20, 50, 100 ng/L were prepared via 
103-fold to 10-fold dilution of the stock solution with Milli-Q water. The resulting standards along with the blank 
samples (n = 12 injections) were analysed with the UHPLC-FSA method at conditions denoted as “standard” in 
Supplementary Table S3.
To construct the calibration curves (n = 5 points), the integrated radiochromatogram peak areas (yP, counts) 
of standard solutions were plotted against the concentration. All standards prepared for calibration curves were 
stored in the fridge at 4 °C before analysis.
Analytical methods. The samples were kept inside the autosampler (Flexar FX UHPLC, Perkin Elmer) at a 
temperature of 4 °C and then injected onto the column thermostated in an LC Column Oven (Flexar LC, Perkin 
Elmer). The guard-column (C18, SecurityGuard Ultra, Phenomenex) was installed for protection of UHPLC 
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column packing. To increase the separation efficiency and, thus, maximise the peak resolution, a long column 
with a core-shell C18 stationary phase (1.7 µm, 100 Å, 150 ×2.1 mm, Kinetex, Phenomenex) was chosen. The 
conventional C18 bonded phase was chosen due to good resolution and retention of steroid compounds58. The 
methanol-water gradient elution was realised by the UHPLC pump (Flexar FX-20, Perkin Elmer). The choice of 
mobile phase was made from the preliminary tests showing a better resolution of E2 and T peaks than that with 
acetonitrile-water elution. The time of changing of mobile phase composition (gradient time) was adjusted for the 
improvement of the peak resolution during the method development. Prior to the liquid flow cell of the radiode-
tector, the UHPLC eluate was mixed in a static mixing tee with the liquid scintillation (LS) cocktail (Ultima Flo 
M, PerkinElmer LAS GmbH, Germany). The LS cocktail was delivered by the internal volume scintillator pump 
of flow scintillation analyser (FSA, Radiomatic 625TR, 500-μL liquid flow cell) (Fig. 1). The activity of the result-
ing mixture was monitored as a count rate using an FSA-detector. The working principle is based on the photon 
counting by means of two photomultiplier tubes (PMT) and a coincidence counting circuit41.
Based on the calibration curves obtained, yP (counts/min) can be converted to the concentration cH and vol-
ume activity aV via Eq. (3) and Eq. (4):
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where S is the slope of the calibration curve of hormones (−) and y0 is the intercept of the calibration curve 
(counts/min).
The main differences of a FSA-detector are that both the sensitivity and the resolution of the peaks for the 
former rely on the size of a flow cell, the ratio between LS cocktail and HPLC eluate, and the update (integra-
tion) time of detector59. Here, a flow cell volume of 500 μL was chosen as a compromise between the achieva-
ble accuracy of measurement due to the higher volume and the dispersion of eluting peak inside the flow cell. 
Additionally, the splitter and diverter lines inside the FSA-detector were bypassed via connecting the column 
outlet directly to the flow-cell.
The effect of LS flow rate on the chromatographic parameters (retention time, shape and area of a peak) was 
carried out with the E2 samples of 100 ng/L and is presented in Supplementary Fig. S1. The narrowest peaks, esti-
mated using the full-width-at-half-maximum (FWHM) values, were observed at LS flow rates greater than 4 mL/
min. This trend could be explained by the reduced peak dispersion inside the flow cell at high flow rates due to a 
decrease of residence time55. Thus, to achieve the highest peak resolution, an LS flow rate of 4 mL/min was fixed 
for all remaining experiments.
The radiochromatograms were obtained from the ProFSA v.3.4.3 software (Perkin Elmer), with a counting 
time of 6 s to ensure an accurate measurement. The peak analysis (retention time and width of peaks) was per-
formed in OriginPro 2017 software (OriginLab).
Error estimation. The error bar of count rate (∆CPM) in quantification example studies was estimated via 
error propagation method considering the uncertainties of sample preparation (∆Prep = 5%), the experimental 
Figure 1. Schematic of the ultra-high-performance liquid chromatography-flow scintillation analysis (UHPLC-
FSA) system with the internal configuration of the FSA-detector.
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system (∆S = 1, 8 and 9%) for adsorption, filtration and photocatalysis studies, UHPLC system (∆UHPLC = 
1%), and FSA-detector (∆Det =12–16%). More details on error estimation can be found in Supplementary 
Information.
Estimation of chromatography resolution and sensitivity. The degree of chromatographic separa-
tion achieved was assessed using the resolution RS value and capacity factor (k), which were calculated in accord-
ance with Eq. (5) and Eq. (6)60:
= .
−
+
R t t
FWHM FWHM
1 18 ,
(5)S
r r2 1
1 2
=
−k t t
t
,
(6)
r 0
0
where tr1,2 are the retention times of analytes of interest (min) and FWHM1,2 are the full-width-at-half-maximum 
values of the analyte peaks (min). A minimum required RS value for adjacent peaks was recommended to be RS > 
2, taken from U. S. Food and Drug Administration (FDA) guideline61, t0 is the dead time of the system, which will 
be determined later (section “Use of tritiated water in UHPLC-FSA analysis”).
Estimation of system response (expressed as peak area in counts/min) at the limit-of-detection (yLOD) and the 
limit-of-quantification (yLOQ) was conducted using the Eq. (7) and Eq. (8)62:
σ= + ⋅y y 3 , (7)LOD B B
σ= + ⋅y y 10 , (8)LOQ B B
where yB is the mean value of blank signal (counts/min) and σB is the standard deviation of the blank signal 
(counts/min).
Results
Separation of hormone mixtures. The results of separation of hormones at ng/L concentrations were 
obtained by injecting the mixtures of E1, E2, T, and P, at 10 and 100 ng/L of each hormone for analysis with the 
UHPLC-FSA method. Figure 2 demonstrates that all the four peaks of E1, E2, T, and P – both at concentra-
tions of 10 and 100 ng/L – were visible despite the strong peak dispersion. The calculated resolution of adjacent 
(close-eluting) peaks, namely RS (E1 - E2) = 1.1, RS (E2 - T) = 2.6 and RS (T - P) = 15.3 confirmed the baseline 
separation for E1 or E2, T and P based on the recommendation RS > 261. Due to the similar interaction of E1 
Figure 2. UHPLC-FSA radiochromatograms of a mixture of 3H-labelled E1, E2, T and P hormones at 
two different concentrations (10 and 100 ng/L of each hormone). The elution conditions are presented in 
Supplementary Table S3 as “standard conditions”.
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and E2 with the C18 stationary phase, the current method resolution was not sufficient to completely avoid their 
co-elution (RS < 2). The key results of UHPLC-FSA separation of hormones are summarised in Table 1. High 
values of capacity factor (k) demonstrated that all hormones are highly retained exceeding the minimum required 
k > 261.
Use of tritiated water in UHPLC-FSA analysis. The separation results of radiolabelled steroid hormones 
were achieved using the method with a pre-selected column type, eluent and elution type. However, further 
optimisation of the UHPLC-FSA method conditions was required. The extra-column volume affects the dis-
persion and hence the resolution of the eluting peaks58, thus it was essential to estimate and reduce the system 
dead volume (V0, the volume between the injection point and FSA-detector) prior to optimisation of separation 
parameters. One approach for determining V0 involves the injection of unretained compounds. When dealing 
with radiochemicals, diluted tritiated water (HTO) is ideally suited for that purpose. Thus, the behaviour of HTO 
samples exhibiting different activity was investigated, with radiochromatograms of such tracer compounds illus-
trated in Supplementary Fig. S2.
HTO elutes at retention time tr = 1.8 ± 0.1 min, with the peak area increasing proportionally to the activity. 
The retention time of HTO was used as the dead time of the system (t0, the transition time of dead volume) for 
calculation of the capacity factor k presented in Table 1. From the t0-value, the dead volume of the system was cal-
culated to be 0.45 mL (of that, 0.26 mL is the estimated column volume). Compared to the conventional UHPLC 
values (μL range)58, the calculated extra-column volume (∼0.2 mL) was found to be excessive. It thus may result 
in post-column dispersion from the mixing parts and flow-cell of FSA-detector and ultimately the absence of 
peak resolution. The work-around of this situation could be an improvement of the chromatographic resolution 
by changing UHPLC operation parameters.
Optimisation of chromatographic conditions for the steroid hormone separation. The 
method development was based on a systematic investigation of the effect of varying four parameters, namely 
UHPLC flow rate, gradient time, column temperature, and volume of injection, which are presented in detail 
in Supplementary Table S3. Such an approach resulted in a solid understanding of how the separation of four 
hormones – E1, E2, T, P – are affected by i) flow rate; ii) gradient time; iii) column temperature; and iv) volume of 
injection. The radiochromatograms of the achieved results are demonstrated in Supplementary Figs. S3–S6. Any 
changes in retention time and peak shape of analytes were reflected in the RS value. From the analysis of obtained 
radiochromatograms for single hormones, the resolution values of adjacent (neighbouring) peaks, RS (E1 - E2), 
RS (E2 - T) and RS (T - P), were estimated (see Fig. 3a–d).
Figure 3a demonstrates the effect of the UHPLC flow rate on the peak resolution, which increased for all 
hormone pairs as the eluent flow rate decreased. On the basis of the RS > 2 goal, it is observed that the successful 
resolution of adjacent peaks of T and P, E2 and T at flow rates less than 0.25 mL/min could be achieved. It was not 
possible to completely resolve the peaks of E1 and E2 due to their partial co-elution. Hence, a flow rate of 0.25 mL/
min was chosen for the separation of hormones to address the trade-off between the analysis time and the peak 
resolution of E2 and T.
In contrast to the eluent flow rate, the gradient time affects the capacity factor by shifting only the retention 
time of analytes of interest. The gradient profiles with the changes of methanol content in the mobile phase over 
the LC runtime can be found in Supplementary Fig. S4a. The correlation between the observed changes in radi-
ochromatograms with the RS values of neighbouring peaks is performed in Fig. 3b. The RS values for all tested 
hormone pairs increased as the methanol-water gradient time increased. At gradient times >25 min, the analyte 
pairs of E2 and T were shown to be potentially resolved (RS > 2), while the peak resolution of T – P pair was high 
even at the shortest gradient time. The close elution of E1 and E2 (RS < 2) was not significantly affected by the 
increase of gradient time. As a trade-off between the analysis time and resolution of E2 and T pair, the gradient 
time of 25 min was chosen for the separation of steroid hormones.
The oven-controlled temperature of the column may affect the viscosity of the solvent, diffusion of analytes 
and selectivity of the column. Hence, the influence of column temperature on the column selectivity (expressed 
via analyte retention times) and peak shape was investigated for tested hormones (see Supplementary Fig. S5 and 
Fig. 3c). In general, RS values did not significantly change with increasing column temperature. The peaks of the 
T - P pair were resolved at all tested temperatures, while the E1 - E2 pair was not possible to resolve. However, 
a major gain in the peak resolution for the E2 - T pair was observed at higher temperatures, which defined the 
choice of the column temperature at 50 °C due to the successful separation of E2 - T analyte pair.
As the injection volume is proportional to the mass of analyte reaching the detector and affecting the 
LOD of the method, a series of injection volumes were tested. As demonstrated in the radiochromatograms 
in Supplementary Fig. S6, the injection volume does not change the analyte retention. In turn, large injection 
volumes leading to extra-column band broadening (observed as an increase of peak width) are known to affect 
Time 
(min)
Capacity factor 
(−)
FWHM 
(min)
Area (counts/
min)
E1 14.0 6.8 0.21 200 ± 18
E2 14.4 7.0 0.24 211 ± 18
T 15.4 7.6 0.21 122 ± 13
P 20.2 10.2 0.16 128 ± 13
Table 1. The UHPLC-FSA separation results of hormone mixture (each 100 ng/L).
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the peak resolution. However, the different volumes of injection did not demonstrate the change of the peak 
resolution expressed as RS value (Fig. 3d). Hence, the volume of injection of 100 μL was chosen to achieve the 
highest sensitivity (by means of increasing the mass of analyte on column) without compromising the resolution 
of adjacent peaks.
Estimation of LOD/LOQ. After the optimisation of separation parameters, the radiochromatograms of 
injected standards were obtained and presented in Supplementary Fig. S7. Based on peak areas obtained from 
these radiochromatograms, the calibration curves for each steroid hormone were constructed (Fig. 4).
The calibration curves for all four hormones demonstrated a good fit (R > 0.996) of linear regression in the 
concentration range of 5–100 ng/L. Based on blank sample injections, the FSA-detector response at LOD (yLOD) 
was calculated to be 53 counts/min. The intercept of calibration curves with yLOD on presented graphs resulted in 
a LOD for tested hormones in the range of 2–4 ng/L. The LOD and LOQ values calculated for steroid hormones 
were summarised in Table 2. The LOQ values for steroid hormones presented in this study were comparable to 
or better than those obtained for non-derivatised estrogens using SPE-UHPLC-MS/MS (5–44 ng/L)37,39,63. Thus, 
the developed method at low sample volumes (<1 mL) appears to be competitive in terms of sensitivity with a 
LC-MS/MS technique. More importantly, it enables the use of LSC methods for testing of mixtures or degradation 
products.
Quantitation of steroid hormones in different water treatment technologies. One of the main 
objectives was to develop a method able to overcome limitations of the LSC method. Those are i) the individual 
analysis of steroid hormones in mixture and ii) the separation and quantification of degradation products. The 
scope of potential applications for the developed method was demonstrated in three water treatment technology 
examples given below and is, of course, expandable to a wealth of research where micropollutant partitioning, 
removal and degradation is to be examined.
Example 1. Adsorption studies. As a first goal, the quantification of removal of multiple hormones pre-
pared in one solution was demonstrated in adsorption studies. For that purpose, the samples collected after static 
adsorption experiments were obtained after 7 h shaking of a mixture of E1, E2, T, and P (each at 100 ng/L) with 
polymer-based spherical activated carbon (PBSAC)64,65. Then, the mixtures of hormones before and after 7 h 
adsorption experiments were compared (see Fig. 5). Details on experiment protocol and material characterization 
can be found elsewhere56.
Figure 3. Influence of (a) UHPLC flow rate, (b) methanol-water gradient time, (c) column temperature, (d) 
volume of injection on the peak resolution of E1–E2, E2–T and T–P pairs obtained from a single hormone 
elution. A recommended RS > 2 for adjacent peaks was marked with a dashed line.
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It was shown using the LSC method that PBSAC achieves a high removal (more than 90%) of individual hor-
mones such as E1, E2, T, and P (each 100 ng/L)56. Figure 5a demonstrates the successful resolution of the adjacent 
peaks of E2, T and P injected as a mixture, despite the partial co-elution of E1 and E2. The radiochromatograms 
also exhibited similar retention times both in the feed (100 and 10 ng/L of each hormone) and after the adsorption 
experiments. The resolution of eluting hormone peaks was not changed at lower concentrations. The advantage 
of this method is that any impurities or oxidation by-products (eluted at tr = 1.5–3 min) were not retained by the 
column so that these would not be considered in the calculation of hormone removal. The hormone mixtures 
before and after adsorption experiments were separated and analysed in terms of removal based on the change 
of peak areas (as seen in Fig. 5b). Apart from partly co-eluting E1 and E2 and, thus, analysed together, the peak 
areas for each individual hormone before the experiment were compared with the ones after 7 h of adsorption 
with PBSAC. The removal of each hormone demonstrated the similar to the previously reported by Tagliavini et 
al. values of around 90%56, with further work showing a significantly higher removal.
Example 2. Nanofiltration of hormone mixtures. Nanofiltration studies were conducted in 
the dead-end stirred cell system43,57,66. The polyamide thin-film-composite nanofiltration membrane (NF 90, 
internal diameter of 7 cm) was used for filtering the mixture of E1, E2, T, and P. The further details on the filtration 
protocol and the system hydrodynamic conditions are given elsewhere64,67. The results of the analysis of collected 
feed and permeate samples are presented in Fig. 6a. The observed peaks were quantified that demonstrated the 
reduction of peak area for E1 (61%), E2 (41%), T (58%) and P (91%) in permeate samples after filtration of 
Figure 4. Calibration curves of (a) E1, (b) E2, (c) T and (d) P. The error bar was calculated as maximum error 
based on at least four repeats. The fitting (solid line) was performed in linear coordinates. The estimated peak 
areas at the limit of detection (yLOD) and the limit of quantification (yLOQ) were demonstrated as dashed lines. 
The details on the estimation of activity at LOD are given in Supplementary Information.
yΒ (counts/ 
min)
σΒ (counts/ 
min)
yLOD (counts/ 
min)
yLOQ (counts/ 
min) S (slope)
LOD 
(ng/L)
LOQ 
(ng/L)
E1
35 6 53 95
22.7 2.4 4.3
E2 19.4 1.7 3.8
T 22.3 1.5 3.4
P 20.7 1.6 3.6
Table 2. Parameters obtained from calibration curves of tested hormones.
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700 mL of feed solution (Fig. 6b). In contrast, the retentate samples demonstrated an increase in peak area for E1 
(71%), E2 (110%), T (94%) and P (6%) due to their rejection by the membrane. It should be noted that the NF90 
membrane was reported to provide 70–80% removal of E2 solutions64. Understanding such differences between 
mixtures and single solutions require further studies.
Example 3. Photocatalytic degradation of hormones. In the photocatalytic degradation tests, the 
E2 hormone solution was continuously pumped through the poly(vinylidene-fluoride) (PVDF) membrane with 
immobilised on its surface Pd(II) meso-Tetra(pentafluorophenyl)porphine (PdTFPP)68. Upon simultaneous 
exposure to the warm-white light-emitting diode (SOLIS-3C, Thorlabs), the photocatalytic membrane produced 
species oxidising E2 molecules. The details on the preparation of the photocatalytic membrane and experimental 
Figure 5. Adsorption experiments with the mixtures of E1, E2, T, and P (100 and 10 ng/L each). (a) UHPLC-
FSA radiochromatograms, (b) the change of obtained peak areas for analytes after 7 h of adsorption experiment. 
The error bar was estimated via error propagation approach as presented in Supplementary Information.
Figure 6. Nanofiltration membrane experiments with the mixtures of E1, E2, T, and P (100 ng/L each). (a) 
UHPLC-FSA radiochromatograms, (b) the normalised peak area for each analyte in feed, permeate and 
retentate samples. The permeate was collected after filtration of 700 mL volume. The error bar was estimated via 
error propagation approach as presented in Supplementary Information.
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protocol were reported in detail elsewhere68. To have the separation of photodegradation products shown, the 
permeate samples collected after photocatalytic degradation of E2 were analysed (Fig. 7a).
After the photocatalytic degradation, the changes in peak height of E2 hormone-containing permeate sam-
ples were observed. The peak area of E2 significantly reduced after the filtration through the light-exposed 
PdTFPP-PVDF membrane. A new peak of unknown metabolite eluting at tr = 7 min was found in the permeate 
samples. Furthermore, multiple peaks of unretained compounds eluting close to the retention time of HTO (tr = 
1–3 min) were observed in the radiochromatogram of permeate samples.
As the quantfication of the separated hormones and their by-products in photodegradation experiments 
was pursued, the integrated areas under peaks before and after the experiment were compared (Fig. 7b). Via 
comparison of peak areas in feed and permeate samples, the removal of E2 (82%) and its conversion to unre-
tained compounds (19%) and new product (39%) may be calculated. Despite the complicated mass balance for 
tritium-labelled compounds42, the total integrated areas representing the activity of samples in the feed and per-
meate were found to be in good agreement.
Discussion
Although analytical techniques for the separation and detection of steroid hormone micropollutants exist, there 
is a lack of methods not requiring complex, multistage sample preparation and low sample volume to detect ng/L 
concentrations. The previous use of highly-sensitive scintillation methods, namely LSC analysis, lacked the ability 
of mixture and/or degradation product separation.
In this study, the UHPLC-FSA method was shown to offer the measurement of 3H-labelled compounds in 
small volumes without the prior pre-concentration at ng/L concentrations. The investigation of separation param-
eters showed that the flow rate and the gradient time had a strong influence on analyte retention. However, a 
limited effect on the peak resolution of E1 and E2 analytes was observed in view of their partial co-elution due to 
a similar interaction with the C18 column. Interestingly, the column temperature improved the selectivity only 
for the E2 - T pair, while no visible change was found for E1 - E2 and T - P pairs. Due to the low concentration of 
samples, the steroid hormone molecules were adsorbed at the head of a column, with the following desorption 
during the gradient elution. Thus, the volume of injection had no significant effect on the shape of peaks.
The LOD (1.5–2.4 ng/L) and LOQ (3.4–4.3 ng/L) of the developed method demonstrate the sensitivity for 
steroid hormones comparable with the modern LC-MS/MS and low sample volumes (5–44 ng/L)37,39,63. As a pos-
sible limitation, the size of a flow cell and counting time are likely to be a bottleneck of the FSA-method in terms 
of further LOD reduction59. Depending on the method objective, either the sensitivity or the peak resolution (as 
trade-off parameters) can be further enhanced by variation of the flow cell geometry and residence time.
Three examples for applying the UHPLC-FSA method in water treatment technologies with sub-mL sample 
injection volumes were demonstrated. An inherent limitation of off-line scintillation methods in view of mix-
ture analysis can be overcome with the UHPLC-FSA. A successful quantification of removal and retention of 
hormone mixtures in adsorption and filtration studies was demonstrated that may give insights into the mech-
anism of removal process in hormone mixtures. Radiochromatograms of collected samples after photocatalytic 
degradation studies showed both the qualitative and quantitative changes of radioactive compounds. Namely, 
the transformation of E2 into a new, more polar, hydroxylated product (E2 + 1O2 ⇒ E2–OH) was detected. Its 
structure is expected to be similar to that of compounds reported in the study of 1O2-mediated degradation of E2 
with Rose Bengal as photosensitiser69. It was assumed that E2 partially converts to unretained compounds and 
the new product during photodegradation.
Figure 7. (a) The UHPLC-FSA radiochromatograms of feed and permeate solutions of E2 at 100 ng/L. (b) The 
change of peak areas for E2, unretained compounds (UCs), metabolite (new product) and total integrated area 
(tr = 0–16 min). The error bar was estimated via the error propagation approach as presented in Supplementary 
Information.
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conclusions
A UHPLC-FSA method was developed to analyse the nanogram-per-litre concentrations of radiolabelled steroid 
hormones (LOD = 1.5–2.4 ng/L and LOQ = 3.4–4.3 ng/L). On the basis of the variation of HPLC and LS flow 
rate, gradient time, column temperature and volume of injection, the method was optimised in terms of peak 
resolution of steroid hormones. Their peaks were clearly visible on the resulted chromatogram, with RS (E2 - T) 
= 2.6, RS (T - P) = 15.3, and RS (E1 - E2) = 1.1 observed as a partial co-elution.
The method was successfully applied in adsorption and filtration experiments for the quantification of hor-
mone mixtures by means of comparison of integrated areas. At tr = 7 min a new metabolite after photodegra-
dation studies was detected and quantified in terms of activity together with initial E2 hormone, unretained 
compounds, and the total integrated area. This study may provide insight into the development of new and exist-
ing water treatment technologies working with radiochemicals in the laboratory environment. The comparison 
of i) real water samples analysed via LC-MS/MS and ii) radiolabelled samples analysed with the UHPLC-FSA 
method would be a valuable future contribution to unveiling the complex process of micropollutant removal.
Data availability
The raw and processed data are available from the corresponding author on request
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